Table 2.

Predictors of high versus low baseline HOMA‐β index among study patients treated with lixisenatide in the unmatched population

Parameters	Odds Ratio	Lower Limit	Upper Limit	P Value*
Age, years	0.993	0.977	1.010	.4274
Sex, female vs male	1.250	0.932	1.676	.1364
Baseline BMI, kg/m2	1.147	1.114	1.182	<.0001
Duration of diabetes, years	0.956	0.929	0.985	.0031
Baseline HbA1c, %	0.799	0.655	0.975	.0270
Baseline FPG, mmol/L	0.983	0.978	0.988	<.0001
Other vs white	0.434	0.176	1.068	.1284
Black or African American vs white	0.925	0.420	2.035	.5025
Asian vs white	0.772	0.465	1.282	.8828
Baseline sulphonylurea usage: Yes vs no	0.672	0.452	1.000	.0502

Abbreviations: BMI, body mass index; FPG, fasting plasma glucose; HbA_1c, glycated haemoglobin; HOMA‐β, homeostasis model assessment of residual β‐cell function.

Bolded values reached statistical significance (P < .05).

^* P value derived from maximum likelihood estimates.